Sex, Lies and Pharmaceuticals: How Drug Companies Are Bankrolling The Next Big Medical Condition For Women

A hard-hitting and provocative expose that takes us inside the corridors of medical power to watch the birth of the new 'disease' - Female Sexual Dysfunction - and the marketing machine that will create it.

'A brilliant dissection of the tragedy of greed preying on fear...this book offers the possibility of a different and less cruel future. Read, think and act!' - Dr Iona Heath, President, Royal College of General Practitioners, London

'An engaging expose of drug company campaigns...' - Amy Allina, National Women's Health Network, Washington DC

'This book tells the story of a turning point, something we may well look back on as a historical event in our lives...Very readable. Chilling.' - Dr Juliet Richters, University of New South Wales

Hard-hitting and provocative, this powerful expoé of the birth of a new 'disease' - and the multi-million dollar machine unleashed to market i - takes us inside the corridors of medical power from Paris to Melbourne to Manhattan to witness the creation of 'female sexual dysfunction' as a twenty-first century epidemic.

The characters in this corporate thriller are the global drug giants, the doctors and psychologists working with them, and the critics trying to untangle medical science from marketing who argue the new disorders of desire are a misleading and dangerous distraction from the real problems in sexual relationships.

With claims that nearly one in two women suffer from 'female sexual dysfunction', some of the most profitable corporations on the planet are poised to exploit some of wome' s deepest fears with hopes for new billion dollar markets.

Set against the great cultural contradictions of our tim - increasing sexual liberation coupled with seemingly increasing sexual anxiet - Sex, Lies and Pharmaceuticals explores with compelling clarity what is really happening as the world prepares for the 'pink' Viagra.

Ray Moynihan is an award-winning investigative journalist and author of three previous books on the business of healthcare, including Selling Sickness which has been sold into the United States and Canada and translated into more than a dozen languages. He is not a friend of the pharmaceutical industry.